AEGiS-SAPA: Catholic Church rolls out Aids drug programme South African Press AssociationImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow


Catholic Church rolls out Aids drug programme

South African Press Association - July 6, 2004


The Catholic Church is planning a further roll-out of its anti-retroviral (ARV) programme for HIV and Aids patients in South Africa, the Southern African Catholic Bishops Conference (SACBC) said on Tuesday.

Of the five million HIV-positive people in South Africa, it is estimated that 600 000 are in need of ARVs, the SACBC said in a statement.

"Take-up" of the Department of Health's roll-out is slow and logistical complications make it impossible for the government to reach everybody.

The Catholic Church has a network of more than 140 service programmes for people living with HIV and Aids in South Africa, making it the largest service provider in the country after the government, the SACBC said.

In February this year the church started rolling out its programme to provide HIV and Aids ARV therapy (HAART) at 22 of its facilities.

Seven of the 22 proposed points of service have already started with HAART, with a combined total of just less than 300 patients.

All other points of service have already identified staff and more than 100 doctors and nurses have been trained in ARV management.

Each point of service is staffed with a medical doctor, a professional nurse and a project coordinator, all of whom are trained in government-accredited ARV management.

It is planned to have all 22 service points operational by February 2005, with 600 patients on HAART at St Mary's hospital (Mariannhill), 300 at Tapologo (Rustenburg), 200 at Sizanani (Bronkhorstspruit) and 100 at each of the remaining 19 points -- a total of 3 000 patients.

This number will be doubled to a total of 6 000 in the second year and doubled again to 12 000 in the third year.

The project is currently funded by Cordaid (The Netherlands) and Pepfar (United States).


040706
SA040702


Copyright © 2004 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .